Valuation: Labcorp Holdings Inc.

Market Cap 24.34B 21.39B 19.91B 18.29B 34.34B 2,334B 34.79B 237B 92.45B 1,152B 91.35B 89.38B 3,983B P/E 2026 *
20.6x
P/E 2027 * 19.4x
Enterprise Value 28.97B 25.47B 23.71B 21.77B 40.88B 2,778B 41.42B 282B 110B 1,372B 109B 106B 4,741B EV / Sales 2026 *
1.97x
EV / Sales 2027 * 1.83x
Free-Float
99.65%
Yield 2026 *
0.98%
Yield 2027 * 0.99%
1 day+1.28%
1 week+6.90%
Current month+7.46%
1 month+7.62%
3 months+14.22%
6 months+10.98%
Current year+19.93%
1 week 277.04
Extreme 277.035
301.79
1 month 262.1
Extreme 262.105
301.79
Current year 245
Extreme 245
301.79
1 year 244.52
Extreme 244.52
301.79
3 years 191.97
Extreme 191.97
301.79
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
7/2/26 A Sell

EVP and President, Diagnostics

-234 0.0003%
7/2/26 A Sell

General Counsel

-92 0.0001%
6/8/26 A Sell

General Counsel

-762 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+6.90%+14.90%+39.27% 24.34B
-1.23%-1.09%+88.24%+473.19% 37.52B
+0.85%-2.19%-23.76%-39.14% 7.33B
-0.24%+1.08%+6.06%+87.00% 4.84B
+3.87%+8.28%+18.76%+51.22% 3.05B
-4.36%-6.67%+105.73%-19.26% 1.81B
+1.81%+0.27%-12.74%-62.95% 1.78B
+3.60%+1.34%-27.61%+750.14% 1.75B
+7.21%-0.36%+14.42%+4.30% 1.74B
+4.98%-9.97%+2.49%-32.21% 1.41B
Average +1.79%-2.20%+18.65%+125.16% 8.56B
Weighted average by Cap. +0.38%-0.79%+43.64%+235.25%

Financials

2026 *2027 *
Net sales 14.71B 12.93B 12.04B 11.06B 20.76B 1,411B 21.03B 143B 55.89B 697B 55.23B 54.04B 2,408B 15.42B 13.55B 12.62B 11.59B 21.76B 1,479B 22.04B 150B 58.57B 730B 57.88B 56.63B 2,523B
Net income 1.17B 1.02B 954M 876M 1.65B 112B 1.67B 11.34B 4.43B 55.2B 4.38B 4.28B 191B 1.22B 1.07B 996M 915M 1.72B 117B 1.74B 11.84B 4.62B 57.62B 4.57B 4.47B 199B
Net Debt 4.63B 4.07B 3.79B 3.48B 6.54B 444B 6.62B 45.07B 17.6B 219B 17.39B 17.02B 758B 3.95B 3.47B 3.23B 2.96B 5.57B 378B 5.64B 38.38B 14.99B 187B 14.81B 14.49B 646B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
27/07/26 $300.87 +1.38% 368,388
24/07/26 $296.77 +1.98% 916,285
23/07/26 $291.02 +3.40% 1,506,096
22/07/26 $281.46 +0.74% 854,980
21/07/26 $279.40 -0.74% 793,930
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
296.77USD
Average target price
312.35USD
Spread / Average Target
+5.25%

Quarterly revenue - Rate of surprise